{
  "casebody": {
    "data": "<casebody firstpage=\"1020\" lastpage=\"1021\" xmlns=\"http://nrs.harvard.edu/urn-3:HLS.Libr.US_Case_Law.Schema.Case_Body:v1\">\n<p data-order=\"0\" data-type=\"docketnumber\" id=\"b1074-16\">51 CCPA</p>\n<parties data-order=\"1\" data-type=\"parties\" id=\"b1074-17\">COMMERCE DRUG COMPANY, Inc. d.b.a. Commerce Drug Co., Appellant, v. BOYLE &amp; COMPANY, Appellee.</parties>\n<docketnumber data-order=\"2\" data-type=\"docketnumber\" id=\"b1074-19\">Patent Appeal No. 7191.</docketnumber>\n<court data-order=\"3\" data-type=\"court\" id=\"b1074-20\">United States Court of Customs and Patent Appeals.</court>\n<decisiondate data-order=\"4\" data-type=\"decisiondate\" id=\"b1074-21\">April 9, 1964.</decisiondate>\n<attorneys data-order=\"5\" data-type=\"attorneys\" id=\"b1075-8\"><page-number citation-index=\"1\" label=\"1021\">*1021</page-number>Richard W. Blum, New York City (Alex Friedman, New York City, and Charles R. Allen, Jr., Washington, D. C., of counsel), for appellant.</attorneys>\n<attorneys data-order=\"6\" data-type=\"attorneys\" id=\"b1075-9\">Theodore W. Miller, Chicago, Ill., for appellee.</attorneys>\n<p data-order=\"7\" data-type=\"judges\" id=\"b1075-10\">Before WORLEY, C. J., and RICH, MARTIN, SMITH, and ALMOND, JJ.</p>\n<opinion data-order=\"8\" data-type=\"opinion\" id=\"x999-1\" type=\"majority\">\n<author id=\"b1075-11\">WORLEY, Chief Judge.</author>\n<p id=\"b1075-12\">Commerce Drug Company asks us to reverse the Trademark Trial and Appeal Board\u2019s decision to cancel its registration <footnotemark>1</footnotemark> of \u201cBOYLENE\u201d for use on an antiseptic preparation for boils. Boyle &amp; Co., petitioner, relies on prior use and registration of \u201cBoyle\u201d<footnotemark>2</footnotemark> on \u201cvitamin capsules, ferrous sulfate tablets, ointment for the treatment of hemorrhoids or piles, diethylstilbestrol tablets, strychnine tonic, tablets used for relief from minor throat irritations, quinidine sulphate tablets, antacid tablets, folic acid tablets, tincture benzoin compound, thyroid powder, rutin tablets, aminophylline tablets, sodium salicylate, laxative tablets, tablets for the treatment of iron deficiency, multi-vitamin preparation and ephedrine sulfate.\u201d</p>\n<p id=\"b1075-13\">The board, after noting that Boyle &amp; Co. is the prior user, and that the competing goods are pharmaceutical preparations, concluded \u201cthat the resemblance between the marks here involved are [sic] such as to be quite likely to cause purchaser confusion, and to lead purchasers to believe that \u2018BOYLENE\u2019 is but another in petitioner\u2019s line of pharmaceutical products.\u201d</p>\n<p id=\"b1075-18\">We find no error in that reasoning or conclusion. While we appreciate appellant\u2019s argument that Boyle is a surname whereas \u201cBOYLENE\u201d is arbitrary, the manner in which Boyle is completely incorporated into Boylene results in a marked similarity of the words.</p>\n<p id=\"b1075-19\">Although appellant emphasizes that there is no evidence of actual confusion, the statutory test is a \u201clikelihood of confusion\u201d which, we have no doubt, is the case here.<footnotemark>3</footnotemark></p>\n<p id=\"b1075-20\">The decision is affirmed.</p>\n<p id=\"b1075-21\">Affirmed.</p>\n<footnote label=\"1\">\n<p id=\"b1075-14\">. Registration No. 714,329, issued April 25, 1961, from an application filed November 13, 1959.</p>\n</footnote>\n<footnote label=\"2\">\n<p id=\"b1075-15\">. Registration No. 510,716, issued June 7, 1949, from an application filed March 11, 1948.</p>\n</footnote>\n<footnote label=\"3\">\n<p id=\"b1075-16\">. \u201cXQ5. Does petitioner put out or distribute and sell an antiseptic preparation for boils under the name of \u2018Boyle\u2019? A. Yes.</p>\n<p id=\"b1075-30\">\u201cXQ6. If your answer to XQ5 is in the affirmative, please annex a \u2018Boyle\u2019 label for such product. A. Attached hereto as Exhibit 4 is a label or photostatic copy thereof of Boyle Drawing Salve.\u201d</p>\n</footnote>\n</opinion>\n</casebody>\n",
    "status": "ok"
  }
}